Global DNA methylome and transcriptome studies from NAFLD patients have shown that DNA methylation is reduced at lipid metabolic genes, such as FASN, ACLY and GPAT131–34. Here, FASN is linked to metabolic dysfunction-associated steatotic liver disease.